OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)
Virginia Clark, Charlie Strange, Pavel Strnad, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 1008-1018.e5
Open Access | Times Cited: 7
Virginia Clark, Charlie Strange, Pavel Strnad, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 1008-1018.e5
Open Access | Times Cited: 7
Showing 7 citing articles:
siRNA-based Delivery Systems: Technologies, Carriers, Applications, and Approved Products
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
European Journal of Pharmacology (2025), pp. 177441-177441
Closed Access
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
European Journal of Pharmacology (2025), pp. 177441-177441
Closed Access
Diagnosis and Monitoring Pathways Using Non‐Invasive Tests in Patients With Alpha‐1 Antitrypsin Deficiency‐Associated Liver Disease: Results From an Expert Delphi Panel
Virginia Clark, Mark Price, Jon Russo, et al.
United European Gastroenterology Journal (2025)
Open Access
Virginia Clark, Mark Price, Jon Russo, et al.
United European Gastroenterology Journal (2025)
Open Access
Severe alpha-1 antitrypsin deficiency shows a higher risk of complications after first decompensation compared to other aetiologies of cirrhosis☆
Lorenz Balcar, Malin Fromme, Naomi Kappe, et al.
JHEP Reports (2025), pp. 101398-101398
Open Access
Lorenz Balcar, Malin Fromme, Naomi Kappe, et al.
JHEP Reports (2025), pp. 101398-101398
Open Access
Fazirsiran als neue Therapieoption bei Alpha-1-Antitrypsinmangel
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. 246-247
Closed Access
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. 246-247
Closed Access
Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicine
Malin Fromme, Fabienne Klebingat, Paul Ellis, et al.
Hepatology Communications (2025) Vol. 9, Iss. 5
Open Access
Malin Fromme, Fabienne Klebingat, Paul Ellis, et al.
Hepatology Communications (2025) Vol. 9, Iss. 5
Open Access
A journey into siRNA therapeutics development: A focus on Pharmacokinetics and Pharmacodynamics
Go-Wun Choi, Ju Hee Kim, Dong‐Wook Kang, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 205, pp. 106981-106981
Open Access | Times Cited: 2
Go-Wun Choi, Ju Hee Kim, Dong‐Wook Kang, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 205, pp. 106981-106981
Open Access | Times Cited: 2
A further step toward possible treatment of alpha-1 antitrypsin deficiency associated liver disease.
Vera Hupertz
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 847-848
Closed Access
Vera Hupertz
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 847-848
Closed Access
Targeted Animal Models for Preclinical Assessment of Cellular and Gene Therapies in Pancreatic and Liver Diseases: Regulatory and Practical Insights
Hongjun Wang, Rachele Ciccocioppo, Shuji Terai, et al.
Cytotherapy (2024)
Closed Access
Hongjun Wang, Rachele Ciccocioppo, Shuji Terai, et al.
Cytotherapy (2024)
Closed Access
